Mark Lappe - Sep 6, 2024 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
Chief Executive Officer, Director
Signature
/s/ Kelly D. Deck, as attorney-in-fact for Mark P. Lappe
Stock symbol
INBX
Transactions as of
Sep 6, 2024
Transactions value $
$671,150
Form type
4
Date filed
9/10/2024, 05:00 PM
Previous filing
Sep 3, 2024
Next filing
Sep 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBX Common Stock Purchase $398K +26K +4.18% $15.29 648K Sep 6, 2024 By the Lappe Family Trust F1, F2
transaction INBX Common Stock Purchase $144K +9.5K +1.47% $15.21 657K Sep 9, 2024 By the Lappe Family Trust F2, F3
transaction INBX Common Stock Purchase $129K +8.5K +1.29% $15.19 666K Sep 10, 2024 By the Lappe Family Trust F2, F4
holding INBX Common Stock 165K Sep 6, 2024 By Lappe Descendants' Trust F5
holding INBX Common Stock 54.9K Sep 6, 2024 The Mark Paul Lappe Roth IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in multiple transactions at prices ranging from $15.04 to $15.70, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.
F3 The shares were purchased in multiple transactions at prices ranging from $15.08 to $15.50, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 The shares were purchased in multiple transactions at prices ranging from $15.01 to $15.26, inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 These securities are directly owned by a trust, for the benefit of the reporting person's immediate family. Mark P. Lappe, as an immediate family member of the beneficiaries of the trust, may be deemed to indirectly beneficially own the securities owned by the trust.